CoChat
Sign Up
Cited by 11Schizophrenia research and treatmentMental Health and PsychiatryPsychological Testing and Assessment

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

A Rating Scale for Psychotic Symptoms (RSPS):

Chouinard, Guy, Miller, Robert·1999·Schizophrenia Research
DOI 10.1016/s0920-9964(99)00013-4
Open this paper in CoChat — free account

Abstract

In the second paper on the Rating Scale for Psychotic Symptoms (RSPS), distraction symptoms (Subscale 2) and delusions (Subscale 3) are described. Subscale 2 includes distraction symptoms, which arise from one of two mechanisms: the symptom may arise either by loss of attentional focus (LAF) due to a competing channel of information, or by the intrusion of the competing channel into the focus of attention [attentional intrusions (AI)]. The symptom classes resulting from loss of attentional focus (LAF) include motor catatonia, negativism, and thought blocking; the attentional intrusions (AI) symptoms rated include three types of passivity experiences (Schneiderian symptoms): (1) thought insertion, (2) movements or action controlled, and (3) speech controlled by an external force. Subscale 3, consisting of delusions, is organized on the basis of content identification. Nineteen types of delusions are rated. Each item of delusional content is rated along three axes (active elaboration, persistence and active extinction) and complexity, and optionally if primary or mixed (i.e. primary with secondary elaborations). The last section of the paper includes the semi-structured interview (SCI-RSPS) for each of the items, as well as guidelines for practical application of the interview.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0920-9964(99)00013-4

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Esketamine has been marketed as a nasal spray approved by the FDA in 2019 for intranasal treatment of treatment-resistant depression in conjunction with an oral antidepressant.

    “Esketamine, the enantiomer of ketamine and an NMDA receptor antagonist, has been marketed as nasal spray approved by the Food and Drug Administration (FDA) in 2019 for intranasal treatment of treatment-resistant depression in conjunction with an oral antidepressant [134, 135].”

    From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [134]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Chouinard, 1980, The extrapyramidal symptom rating scale, Can. J. Neurol., 7, 233
  2. Miller, 1991, Cortico-striatal cell assemblies in selective attention and in representation of predictable and controllable events. A general statement of corticostriatal interplay and the role of striatal dopamine, Concepts Neurosci., 2, 65

Cited by

Sorted by citations

Related

Metadata

Authors
Chouinard, G., & Miller, R.
Affiliations
  • Institut universitaire en santé mentale de Montréal (CA)
  • University of Otago (NZ)
Corresponding author
Chouinard, Guy
ORCID
Miller, Robert
Venue
Schizophrenia Research
Publisher
Elsevier BV
Published
1999-08
Volume
38
Issue
2-3
Pages
123-150
ISSN
0920-9964 (ISSN-L)
DOI
10.1016/s0920-9964(99)00013-4
OpenAlex
W2616363767
Cited by
11
References
14
Citations by year
2025: 1 · 2020: 1 · 2017: 2 · 2016: 1
FWCI
0.24
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Schizophrenia Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Health Research Council of New Zealand
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
  • Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Keywords
psychotic symptoms
MeSH terms
Association, Attention, Cerebral Cortex, Cognition Disorders, Corpus Striatum, Delusions, Dopamine, Extinction, Psychological, Fear, Humans, Inhibition, Psychological, Interview, Psychological, Neural Pathways, Neuropsychological Tests, Perceptual Masking, Psychiatric Status Rating Scales, Psychotic Disorders, Reward, Volition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review